MedTrace Logo

Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.

NCT06638567 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1008

Last updated 2025-01-30

No results posted yet for this study

Summary

A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol/L, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.

Conditions

  • Diabetes Mellitus, Type 2
  • Surgical Site Infection

Interventions

OTHER

Basal bolus insulin regimen

Combination of long-acting and short-acting insulin in a proactive schedule for achieving better blood glucose values postoperatively

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Abraham Hulst, MD, PhD

    lead OTHER

Principal Investigators

  • Sarah E. Siegelaar, MD, PhD · Amsterdam UMC, location AMC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-03
Primary Completion
2027-02-28
Completion
2027-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06638567 on ClinicalTrials.gov